Literature DB >> 26970355

Spinal activity of interleukin 6 mediates myelin basic protein-induced allodynia.

Justin S Ko1, Kelly A Eddinger2, Mila Angert3, Andrei V Chernov4, Jennifer Dolkas3, Alex Y Strongin4, Tony L Yaksh2, Veronica I Shubayev5.   

Abstract

Mechanosensory fibers are enveloped by myelin, a unique multilamellar membrane permitting saltatory neuronal conduction. Damage to myelin is thought to contribute to severe pain evoked by innocuous tactile stimulation (i.e., mechanical allodynia). Our earlier (Liu et al., 2012) and present data demonstrate that a single injection of a myelin basic protein-derived peptide (MBP84-104) into an intact sciatic nerve produces a robust and long-lasting (>30days) mechanical allodynia in female rats. The MBP84-104 peptide represents the immunodominant epitope and requires T cells to maintain allodynia. Surprisingly, only systemic gabapentin (a ligand of voltage-gated calcium channel α2δ1), but not ketorolac (COX inhibitor), lidocaine (sodium channel blocker) or MK801 (NMDA antagonist) reverse allodynia induced by the intrasciatic MBP84-104. The genome-wide transcriptional profiling of the sciatic nerve followed by the bioinformatics analyses of the expression changes identified interleukin (IL)-6 as the major cytokine induced by MBP84-104 in both the control and athymic T cell-deficient nude rats. The intrasciatic MBP84-104 injection resulted in both unilateral allodynia and unilateral IL-6 increase the segmental spinal cord (neurons and astrocytes). An intrathecal delivery of a function-blocking IL-6 antibody reduced the allodynia in part by the transcriptional effects in large-diameter primary afferents in DRG. Our data suggest that MBP regulates IL-6 expression in the nervous system and that the spinal IL-6 activity mediates nociceptive processing stimulated by the MBP epitopes released after damage or disease of the somatosensory nervous system. Published by Elsevier Inc.

Entities:  

Keywords:  Adaptive immunity; Allodynia; Autoimmunity and pain; Cacna2d1; Chronic pain; Female pain; Gabapentin; Interferon; Interleukin 6; MBP; Mechanical hypersensitivity; Myelin; Myelin basic protein; Neuropathic pain; Nude rat; T cells

Mesh:

Substances:

Year:  2016        PMID: 26970355      PMCID: PMC4917441          DOI: 10.1016/j.bbi.2016.03.003

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  83 in total

Review 1.  Immune circuitry in the peripheral nervous system.

Authors:  Bernd C Kieseier; Hans-Peter Hartung; Heinz Wiendl
Journal:  Curr Opin Neurol       Date:  2006-10       Impact factor: 5.710

Review 2.  Central sensitization and Ca(V)α₂δ ligands in chronic pain syndromes: pathologic processes and pharmacologic effect.

Authors:  Michael Tuchman; Jeannette A Barrett; Sean Donevan; Thomas G Hedberg; Charles P Taylor
Journal:  J Pain       Date:  2010-05-15       Impact factor: 5.820

3.  Classical 18.5-and 21.5-kDa isoforms of myelin basic protein inhibit calcium influx into oligodendroglial cells, in contrast to golli isoforms.

Authors:  Graham S T Smith; Pablo M Paez; Vilma Spreuer; Celia W Campagnoni; Joan M Boggs; Anthony T Campagnoni; George Harauz
Journal:  J Neurosci Res       Date:  2011-01-13       Impact factor: 4.164

4.  Induction of interleukin-6 by depolarization of neurons.

Authors:  S Sallmann; E Jüttler; S Prinz; N Petersen; U Knopf; T Weiser; M Schwaninger
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

5.  Endogenous interleukin-6 contributes to hypersensitivity to cutaneous stimuli and changes in neuropeptides associated with chronic nerve constriction in mice.

Authors:  P G Murphy; M S Ramer; L Borthwick; J Gauldie; P M Richardson; M A Bisby
Journal:  Eur J Neurosci       Date:  1999-07       Impact factor: 3.386

6.  The differential role of spinal MHC class II and cellular adhesion molecules in peripheral inflammatory versus neuropathic pain in rodents.

Authors:  S M Sweitzer; K A White; C Dutta; J A DeLeo
Journal:  J Neuroimmunol       Date:  2002-04       Impact factor: 3.478

7.  Up-regulation of leukaemia inhibitory factor and interleukin-6 in transected sciatic nerve and muscle following denervation.

Authors:  J B Kurek; L Austin; S S Cheema; P F Bartlett; M Murphy
Journal:  Neuromuscul Disord       Date:  1996-03       Impact factor: 4.296

8.  MMPs initiate Schwann cell-mediated MBP degradation and mechanical nociception after nerve damage.

Authors:  Hideo Kobayashi; Sharmila Chattopadhyay; Kinshi Kato; Jennifer Dolkas; Shin-Ichi Kikuchi; Robert R Myers; Veronica I Shubayev
Journal:  Mol Cell Neurosci       Date:  2008-09-05       Impact factor: 4.314

9.  Quantitative assessment of tactile allodynia in the rat paw.

Authors:  S R Chaplan; F W Bach; J W Pogrel; J M Chung; T L Yaksh
Journal:  J Neurosci Methods       Date:  1994-07       Impact factor: 2.390

10.  Human MBP-specific T cells regulate IL-6 gene expression in astrocytes through cell-cell contacts and soluble factors.

Authors:  M Colombatti; G Moretto; M Tommasi; E Fiorini; O Poffe; M Colombara; R Tanel; G Tridente; D Ramarli
Journal:  Glia       Date:  2001-09       Impact factor: 7.452

View more
  11 in total

1.  A sensitive and selective ELISA methodology quantifies a demyelination marker in experimental and clinical samples.

Authors:  Albert G Remacle; Jennifer Dolkas; Mila Angert; Swathi K Hullugundi; Andrei V Chernov; R Carter W Jones; Veronica I Shubayev; Alex Y Strongin
Journal:  J Immunol Methods       Date:  2018-02-08       Impact factor: 2.303

2.  A myelin basic protein fragment induces sexually dimorphic transcriptome signatures of neuropathic pain in mice.

Authors:  Andrei V Chernov; Swathi K Hullugundi; Kelly A Eddinger; Jennifer Dolkas; Albert G Remacle; Mila Angert; Brian P James; Tony L Yaksh; Alex Y Strongin; Veronica I Shubayev
Journal:  J Biol Chem       Date:  2020-06-12       Impact factor: 5.157

3.  Amino acid sequence conservation of the algesic fragment of myelin basic protein is required for its interaction with CDK5 and function in pain.

Authors:  Andrei V Chernov; Albert G Remacle; Swathi K Hullugundi; Piotr Cieplak; Mila Angert; Jennifer Dolkas; Veronica I Shubayev; Alex Y Strongin
Journal:  FEBS J       Date:  2018-08-27       Impact factor: 5.542

4.  Insulin Promotes Schwann-Like Cell Differentiation of Rat Epidermal Neural Crest Stem Cells.

Authors:  Pariya Khodabakhsh; Safura Pournajaf; Leila Mohaghegh Shalmani; Abolhassan Ahmadiani; Leila Dargahi
Journal:  Mol Neurobiol       Date:  2021-07-23       Impact factor: 5.590

Review 5.  Molecules in pain and sex: a developing story.

Authors:  Josiane C S Mapplebeck; Simon Beggs; Michael W Salter
Journal:  Mol Brain       Date:  2017-03-07       Impact factor: 4.041

6.  Activation of spinal dorsal horn P2Y13 receptors can promote the expression of IL-1β and IL-6 in rats with diabetic neuropathic pain.

Authors:  Rui Zhou; Tao Xu; XiaoHong Liu; YuanShou Chen; DeYing Kong; Hong Tian; Mingxia Yue; Dujuan Huang; Junwei Zeng
Journal:  J Pain Res       Date:  2018-03-27       Impact factor: 3.133

Review 7.  Structural homology of myelin basic protein and muscarinic acetylcholine receptor: Significance in the pathogenesis of complex regional pain syndrome.

Authors:  Veronica I Shubayev; Alex Y Strongin; Tony L Yaksh
Journal:  Mol Pain       Date:  2018-11-05       Impact factor: 3.370

8.  Sexual Dimorphism of Early Transcriptional Reprogramming in Dorsal Root Ganglia After Peripheral Nerve Injury.

Authors:  Andrei V Chernov; Veronica I Shubayev
Journal:  Front Mol Neurosci       Date:  2021-12-13       Impact factor: 6.261

9.  Sex-Specific B Cell and Anti-Myelin Autoantibody Response After Peripheral Nerve Injury.

Authors:  Hee Jong Lee; Albert G Remacle; Swathi K Hullugundi; Jennifer Dolkas; Jake B Leung; Andrei V Chernov; Tony L Yaksh; Alex Y Strongin; Veronica I Shubayev
Journal:  Front Cell Neurosci       Date:  2022-04-14       Impact factor: 6.147

10.  Role of myelin auto-antigens in pain: a female connection.

Authors:  Veronica I Shubayev; Alex Y Strongin; Tony L Yaksh
Journal:  Neural Regen Res       Date:  2016-06       Impact factor: 6.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.